Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease.
Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease.
复制标题
DOI:
10.1111/apt.13777
复制
发表时间:
2016-10
影响因子:
7.6
通讯作者:
Gyawali CP
中科院分区:
文献类型:
--
作者:
Patel A;Wang D;Sainani N;Sayuk GS;Gyawali CP
Mean nocturnal baseline impedance (MNBI), a novel pH-impedance metric, may be a surrogate marker of reflux burden. To assess the predictive value of MNBI on symptomatic outcomes after antireflux therapy. In this prospective observational cohort study, pH-impedance studies performed over a 5-year period were reviewed. Baseline impedance was extracted from 6 channels at three stable nocturnal 10-min time periods, and averaged to yield MNBI. Distal and proximal esophageal MNBI values were calculated by averaging MNBI values at 3, 5, 7, and 9 cm, and 15 and 17 cm, respectively. Symptomatic outcomes were measured as changes in global symptom severity (GSS, rated on 100-mm visual analog scales) on prospective follow-up after medical or surgical antireflux therapy. Univariate and multivariate analyses assessed the predictive value of MNBI on symptomatic outcomes. Of 266 patients, 135 (50.8%) were tested off PPI therapy and formed the study cohort (52.1±1.1 yrs, 63.7% F). The 59 with elevated acid exposure time (AET) had lower composite and distal MNBI values than those with physiologic AET (p<0.0001), but similar proximal MNBI (p=0.62). Linear AET negatively correlated with distal MNBI, both individually and collectively (Pearson's r=−0.5, p<0.001), but not proximal MNBI (Pearson's r=0, p=0.72). After prospective follow-up (94 patients followed for 3.1±0.2 yrs), univariate and multivariate regression models showed that distal MNBI, but not proximal MNBI, was independently predictive of linear GSS improvement. Distal esophageal MNBI negatively correlates with AET and, when assessed off PPI therapy, is independently predictive of symptomatic improvement following antireflux therapy.
登录
查看更多内容
影响因子:
9.8
作者:
Kessing, Boudewijn F.;Bredenoord, Albert J.;Smout, A. J. P. M.
通讯作者:
Smout, A. J. P. M.
影响因子:
3.5
作者:
Patel A;Sayuk GS;Kushnir VM;Chan WW;Gyawali CP
通讯作者:
Gyawali CP
影响因子:
12.6
作者:
Kandulski, Arne;Weigt, Jochen;Malfertheiner, Peter
通讯作者:
Malfertheiner, Peter
影响因子:
7.6
作者:
Sifrim, D.;Mittal, R.;Gregersen, H.
通讯作者:
Gregersen, H.
影响因子:
12.6
作者:
Zerbib, Frank;Roman, Sabine;Mion, Francois
通讯作者:
Mion, Francois